Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Barnard

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: Sch-58500, CanjiD L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Genvir (Flamel Technologies)D L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Pegasys (Hoffmann-La Roche)D L Barnard
Metabolism: Clinical and Experimental|November 1, 1970
Correspondence: changes in body composition produced by prolonged total starvation and refeedingD L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
RWJ-270201 BioCryst Pharmaceuticals/Johnson & JohnsonD L Barnard
Idrugs : the Investigational Drugs Journal|December 1, 2004
Antiviral Research - 15th International Conference. Mega-HAART and tenofovir. 17-21 March 2002, Prague, Czech RepublicD L Barnard
Idrugs : the Investigational Drugs Journal|August 5, 2005
Antiviral research - 13th International ConferenceD L Barnard
Journal of Clinical Pathology|November 1, 1983
Mean platelet volume changes in infectionG Robbins, D L Barnard
Acta Haematologica|January 1, 1983
Thrombocytosis and microthrombocytosis: a clinical evaluation of 372 casesG Robbins, D L Barnard
Gut|April 1, 1973
Bile acids and vitamin A absorption in man: the effects of two bile acid-binding agents, cholestyramine and ligninD L Barnard, K W Heaton
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: Sch-58500, CanjiD L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Genvir (Flamel Technologies)D L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Pegasys (Hoffmann-La Roche)D L Barnard
Metabolism: Clinical and Experimental|November 1, 1970
Correspondence: changes in body composition produced by prolonged total starvation and refeedingD L Barnard
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
RWJ-270201 BioCryst Pharmaceuticals/Johnson & JohnsonD L Barnard
Idrugs : the Investigational Drugs Journal|December 1, 2004
Antiviral Research - 15th International Conference. Mega-HAART and tenofovir. 17-21 March 2002, Prague, Czech RepublicD L Barnard
Idrugs : the Investigational Drugs Journal|August 5, 2005
Antiviral research - 13th International ConferenceD L Barnard
Journal of Clinical Pathology|November 1, 1983
Mean platelet volume changes in infectionG Robbins, D L Barnard
Acta Haematologica|January 1, 1983
Thrombocytosis and microthrombocytosis: a clinical evaluation of 372 casesG Robbins, D L Barnard
Gut|April 1, 1973
Bile acids and vitamin A absorption in man: the effects of two bile acid-binding agents, cholestyramine and ligninD L Barnard, K W Heaton
Pageof 7